SDZ

Sandoz Grp Stock

StockStock
ISIN: CH1243598427
Ticker: SDZ
CH1243598427
SDZ

Price

Historical dividends and forecast

All dividend data

Sandoz Grp has so far distributed $0.495 in 2024. The next dividend will be paid on 07.05.2025


$0.501

CHART BY

Frequently asked questions

What is Sandoz Grp's market capitalization?

The market capitalization of Sandoz Grp is $20.11B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What are the analyst ratings and target price for Sandoz Grp's stock?

Currently, 13 analysts cover Sandoz Grp's stock, with a consensus target price of $41.99. Analyst ratings provide insights into the stock's expected performance.

How many employees does Sandoz Grp have, and what sector and industry does it belong to?

Sandoz Grp employs approximately 23,848 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Sandoz Grp's shares?

The free float of Sandoz Grp is 421.00M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 
$20.11B

Free Float

 
421.00M

Pricing

1D span
$44.73$45.73
52W span
$27.89$47.08

Analyst Ratings

The price target is $41.99 and the stock is covered by 13 analysts.

Buy

10

Hold

3

Sell

0

Information

Sandoz Group AG is a Switzerland based company which is active in healthcare technology industry. The Company operates in two businesses, Generics and Biosimilars. Generics business develops, manufacture and market active ingredients and finished dosage forms of small molecule pharmaceuticals, finished dosage forms of anti-infectives and active pharmaceutical ingredients and intermediates. Biosimilars business develops, manufacture and market protein-based and other biological products which are similar to another already approved biological medicines. Company’s product portfolio comprising Generics and Biosimilars covers all therapeutic areas for patient treatment such as cardiovascular, central nervous system, oncology, anti-infectives, pain and respiratory. The Company serves customers worldwide.

23,848

Biotechnology & Drugs

Health Care

Identifier

ISIN

CH1243598427

Primary Ticker

SDZ

Knockouts

Join the conversation